mspWarsaw, IN, January 26, 2015 – Nextremity Solutions® announces that it will launch the MSP™Metatarsal Shortening System at the American College of Foot and Ankle Surgeons (ACFAS) 2015 Scientific Conference on February 19, 2015 in Phoenix, AZ.

This MSP is designed to provide surgeons with controlled shortening of the metatarsal, without plantar displacement, though a first of its kind, integrated osteotomy guide and implant design.

Nick A. Deeter, CEO and Chairman of Nextremity Solutions® commented, “We are very pleased by the overwhelmingly favorable surgeon feedback on the MSP™ Metatarsal Shortening System.  It is important to us that we continue to provide a diverse portfolio of forefoot solutions to our surgeon customers. We anticipate that MSP’s unique features, integrated osteotomy guide and keeled design will provide surgeons with better results for metatarsal shortening.”

Rod K. Mayer, President of Nextremity Solutions® remarked, “The combination of Nextra®, Re+Line™ and now MSP™, provides us with a highly differentiated product presence in the two largest and fastest growing foot and ankle surgery segments.  MSP™was designed by surgeons for surgeons. We couldn’t think of a better place to launch MSP™than at the annual ACFAS meeting.”

Nextremity Solutions® will be featuring this new product, along with its entire portfolio of forefoot solutions at their booth and through a special interactive, hands-on experience February 19th at 7:30PM.  Visit to learn more.


The American College of Foot and Ankle Surgeons (ACFAS) is a professional society of more than 7,000 foot and ankle surgeons. Founded in 1942, ACFAS seeks to promote the art and science of foot, ankle and related lower extremity surgery; address the concerns of foot and ankle surgeons; ensure superb patient care; and advance and improve standards of education and surgical skill.

About Nextremity Solutions, Inc.

Nextremity Solutions® is a privately held medical device company offering innovative solutions and approaches to foot and ankle surgical intervention. The Company’s procedure-ready, sterile implant systems for the correction of foot and ankle pathologies include uniquely precise, proprietary technology designed to achieve repeatable and superior clinical outcomes.

For further information, visit or call Dave Temple, Director of Marketing at 574-635-3023.